Related Experiment Video
Updated: Feb 20, 2026
Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers
Published on: March 6, 2009
Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T
Samantha Reiss1, Amy E Baxter2,3, Kimberly M Cirelli1
1Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
Insights
Identifying rare antigen-specific CD4 T cells is crucial for immunology. New Activation Induced Marker (AIM) assays offer a sensitive method to detect these cells, improving vaccine and infectious disease research.
Area of Science:
- Immunology
- Cellular Immunology
- Vaccinology
Background:
- Antigen-specific CD4 T cells are vital for understanding immune responses.
- Their rarity and heterogeneity complicate detection using traditional methods.
- Accurate identification is key for vaccine development and infectious disease research.
Purpose of the Study:
- To develop and compare sensitive assays for detecting antigen-specific CD4 T cells.
- To evaluate Activation Induced Marker (AIM) assays for their efficacy.
- To validate these assays in human and non-human primate studies.
Main Methods:
- Development of novel AIM assays utilizing markers like CD69, CD40L, OX40, CD25, PD-L1, and 4-1BB.
- Head-to-head comparison of assay sensitivity for vaccine and infection-induced responses.
- Assessment of bystander activation and T regulatory cell interference.
- Validation in human and non-human primate (Macaca mulatta) samples.
Main Results:
- AIM assays provide highly sensitive detection of antigen-specific CD4 T cells.
- Different AIM assays identify distinct yet overlapping T cell populations.
- A subset of antigen-specific CD4 T cells can also be identified by cytokine production.
- AIM assays are minimally affected by bystander activation, with specific validation against T regulatory cell interference.
Conclusions:
- AIM assays are a sensitive and valuable tool for identifying antigen-specific CD4 T cells.
- Methodological improvements enhance the reliability of AIM assays.
- These assays advance research in immunology, vaccinology, and infectious diseases.
Abstract:
The identification and study of antigen-specific CD4 T cells, both in peripheral blood and in tissues, is key for a broad range of immunological research, including vaccine responses and infectious diseases. Detection of these cells is hampered by both their rarity and their heterogeneity, in particular with regards to cytokine secretion profiles. These factors prevent the identification of the total pool of antigen-specific CD4 T cells by classical methods. We have developed assays for the highly sensitive detection of such cells by measuring the upregulation of surface activation induced markers (AIM). Here, we compare two such assays based on concurrent expression of CD69 plus CD40L (CD154) or expression of OX40 plus CD25, and we develop additional AIM assays based on OX40 plus PD-L1 or 4-1BB. We compare the relative sensitivity of these assays for detection of vaccine and natural infection-induced CD4 T cell responses and show that these assays identify distinct, but overlapping populations of antigen-specific CD4 T cells, a subpopulation of which can also be detected on the basis of cytokine synthesis. Bystander activation had minimal effect on AIM markers. However, some T regulatory cells upregulate CD25 upon antigen stimulation. We therefore validated AIM assays designed to exclude most T regulatory cells, for both human and non-human primate (NHP, Macaca mulatta) studies. Overall, through head-to-head comparisons and methodological improvements, we show that AIM assays represent a sensitive and valuable method for the detection of antigen-specific CD4 T cells.
